Gut Health: The value of connections
The human gut is home to over 30 trillion microbes that form a complex ecosystem (Sender et al., 2016). Each person has a unique and dynamic set of microorganisms in their gut, and researchers have long tried to identify and untangle the reasons for this remarkable variation. The list of factors determining which microbes colonize an individual’s gut is extensive, ranging from diet to contact with pets and farm animals, geographical location, ethnicity, history of medications, and various other individual and lifestyle characteristics (Parizadeh and Arrieta, 2023).
The composition of the gut microbiome has also been linked to a range of health conditions, with loss of species diversity being a common hallmark of disturbed microbiomes (Bidell et al., 2022). These associations have fuelled the idea that the gut microbiome can be used as a non-invasive biomarker of health status, or to improve and maintain human health by introducing beneficial bacteria and removing pathogens from the gut.
However, it is still largely unclear whether changes in the microbiome are the cause or consequence of disease. The challenges in teasing apart the many intricate factors shaping microbiome composition constitute a major roadblock to translating the vast body of microbiome research into clinical practices. Now, in eLife, Iva Veseli (University of Chicago), Jessika Füssel, A. Murat Eren and colleagues report that the extent to which bacteria can synthetize their own food is a significant trait determining the composition of unhealthy gut microbiomes (Veseli et al., 2023).
The team – who are based at various research institutes in the United States, Denmark and Germany – analysed gut microbiomes associated with inflammatory bowel disease (IBD) and other gastrointestinal conditions. The diversity of microbes in these communities is typically low due to antibiotics, diarrhoea and other features linked to a stressed gut environment. Unlike most previous studies that looked at taxonomic or species composition, Veseli et al. investigated the genome content of bacteria, focusing on their capacity to produce and metabolize essential nutrients, such as amino acids, carbohydrates and vitamins.
They found that stressed gut environments contained bacteria whose genomes encoded complete pathways to biosynthesise essential nutrients – i.e., they show high metabolic independence. In contrast, bacterial genomes from healthy individuals contained seemingly incomplete metabolic pathways, suggesting that they rely more extensively on nutrients produced by their peers to survive, also known as cross-feeding (Figure 1).
Next, Veseli et al. asked whether the overall metabolic independence of gut bacteria could be used as a biomarker of health status. First, the team developed an open-source software platform to systematically quantify metabolic independence from high-throughput sequencing data. They applied their newly developed approach to over 300 deeply sequenced stool samples from individuals with IBD and healthy controls. They then showed that, with the help of machine learning, it is indeed possible to accurately identify individuals with IBD based entirely on the estimated self-sufficiency of their microbiome.
To expand the scope of their findings beyond IBD, Veseli et al. showed that a short dose of antibiotics taken by healthy volunteers leads to a sharp increase in the proportions of self-sufficient gut bacteria, followed by a gradual recovery of bacteria that seem to rely on cross-feeding. These results support the claim that high metabolic independence is a hallmark of poorly diverse, stressed gut ecosystems, which can be used as a biomarker of gut health status. Since it is based on mechanisms rather than the taxonomic identity of microbiome members, the approach proposed by Veseli et al. is likely to be more robust to the ethnicity, geographic location and lifestyle factors that have obscured associations between microbiomes and health status in the past (Sze and Schloss, 2016; Gaulke and Sharpton, 2018).
The implications of this study bring a new perspective to the microbiome field. Bacteria typically labelled as pathogens for their association with unhealthy microbiomes might not be causative disease agents as previosuly assumed. Instead, they might simply be the only ones capable of surviving in a poorly diverse gut. The study also adds key evidence to the growing awareness of the relationships between microbial cross-feeding and microbiome composition, paving the way to test interesting questions in future research (Wang et al., 2019; Marcelino et al., 2023; Gralka et al., 2020; Watson et al., 2023). For example, what are the roles of bacteria with high metabolic independence in re-establishing a healthy gut microbiome after disruption? If self-sufficient bacteria are at the bottom of the microbial food chain, one can wonder whether these presumed villains will become heroes in restoring the gut ecosystem. These new perspectives bring us one step closer to fully benefit from the diagnostic and therapeutic potential of the human gut microbiome.
References
-
Gut microbiome health and dysbiosis: A clinical primerPharmacotherapy 42:849–857.https://doi.org/10.1002/phar.2731
-
Trophic interactions and the drivers of microbial community assemblyCurrent Biology 30:R1176–R1188.https://doi.org/10.1016/j.cub.2020.08.007
-
The global human gut microbiome: genes, lifestyles, and dietTrends in Molecular Medicine 29:789–801.https://doi.org/10.1016/j.molmed.2023.07.002
-
Evidence for a multi-level trophic organization of the human gut microbiomePLOS Computational Biology 15:e1007524.https://doi.org/10.1371/journal.pcbi.1007524
Article and author information
Author details
Publication history
- Version of Record published: September 19, 2023 (version 1)
Copyright
© 2023, Rossetto Marcelino
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 682
- views
-
- 49
- downloads
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Computational and Systems Biology
Imputing data is a critical issue for machine learning practitioners, including in the life sciences domain, where missing clinical data is a typical situation and the reliability of the imputation is of great importance. Currently, there is no canonical approach for imputation of clinical data and widely used algorithms introduce variance in the downstream classification. Here we propose novel imputation methods based on determinantal point processes (DPP) that enhance popular techniques such as the multivariate imputation by chained equations and MissForest. Their advantages are twofold: improving the quality of the imputed data demonstrated by increased accuracy of the downstream classification and providing deterministic and reliable imputations that remove the variance from the classification results. We experimentally demonstrate the advantages of our methods by performing extensive imputations on synthetic and real clinical data. We also perform quantum hardware experiments by applying the quantum circuits for DPP sampling since such quantum algorithms provide a computational advantage with respect to classical ones. We demonstrate competitive results with up to 10 qubits for small-scale imputation tasks on a state-of-the-art IBM quantum processor. Our classical and quantum methods improve the effectiveness and robustness of clinical data prediction modeling by providing better and more reliable data imputations. These improvements can add significant value in settings demanding high precision, such as in pharmaceutical drug trials where our approach can provide higher confidence in the predictions made.
-
- Computational and Systems Biology
Interacting molecules create regulatory architectures that can persist despite turnover of molecules. Although epigenetic changes occur within the context of such architectures, there is limited understanding of how they can influence the heritability of changes. Here, I develop criteria for the heritability of regulatory architectures and use quantitative simulations of interacting regulators parsed as entities, their sensors, and the sensed properties to analyze how architectures influence heritable epigenetic changes. Information contained in regulatory architectures grows rapidly with the number of interacting molecules and its transmission requires positive feedback loops. While these architectures can recover after many epigenetic perturbations, some resulting changes can become permanently heritable. Architectures that are otherwise unstable can become heritable through periodic interactions with external regulators, which suggests that mortal somatic lineages with cells that reproducibly interact with the immortal germ lineage could make a wider variety of architectures heritable. Differential inhibition of the positive feedback loops that transmit regulatory architectures across generations can explain the gene-specific differences in heritable RNA silencing observed in the nematode Caenorhabditis elegans. More broadly, these results provide a foundation for analyzing the inheritance of epigenetic changes within the context of the regulatory architectures implemented using diverse molecules in different living systems.